| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear body | PPARGC1A SETX EHMT2 ZC3H13 SETBP1 MKI67 ASCC2 DKC1 GON4L PIP5K1A SREK1 CWC22 REXO1 PRPF18 | 8.75e-06 | 903 | 81 | 14 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MSH6 NABP2 ASCC2 DKC1 GON4L PIP5K1A AFF1 TSEN54 SREK1 NABP1 MGA CWC22 PRPF18 MED12 AFF4 NUP205 RAD50 | 1.71e-05 | 1377 | 81 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | SOSS complex | 8.85e-05 | 4 | 81 | 2 | GO:0070876 | |
| GeneOntologyCellularComponent | super elongation complex | 2.20e-04 | 6 | 81 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | fibrillar center | 3.52e-04 | 156 | 81 | 5 | GO:0001650 | |
| MousePheno | decreased pre-B cell number | 1.67e-05 | 67 | 67 | 5 | MP:0008209 | |
| Domain | TF_AF4/FMR2 | 1.11e-04 | 4 | 81 | 2 | IPR007797 | |
| Domain | AF-4 | 1.11e-04 | 4 | 81 | 2 | PF05110 | |
| Domain | PDZ | 5.05e-04 | 151 | 81 | 5 | PS50106 | |
| Domain | - | 5.11e-04 | 8 | 81 | 2 | 3.30.890.10 | |
| Domain | PDZ | 5.21e-04 | 152 | 81 | 5 | IPR001478 | |
| Domain | KRAB_RELATED | 9.96e-04 | 11 | 81 | 2 | PS50806 | |
| Domain | Methyl_CpG_DNA-bd | 9.96e-04 | 11 | 81 | 2 | IPR001739 | |
| Domain | MBD | 9.96e-04 | 11 | 81 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 9.96e-04 | 11 | 81 | 2 | IPR016177 | |
| Domain | MBD | 9.96e-04 | 11 | 81 | 2 | SM00391 | |
| Domain | MBD | 9.96e-04 | 11 | 81 | 2 | PS50982 | |
| Domain | tRNA_anti-codon | 1.19e-03 | 12 | 81 | 2 | PF01336 | |
| Domain | NA-bd_OB_tRNA | 1.19e-03 | 12 | 81 | 2 | IPR004365 | |
| Domain | Krueppel-associated_box-rel | 1.40e-03 | 13 | 81 | 2 | IPR003655 | |
| Domain | AT_hook | 2.14e-03 | 16 | 81 | 2 | PF02178 | |
| Domain | DSRM | 3.03e-03 | 19 | 81 | 2 | SM00358 | |
| Domain | PDZ | 3.30e-03 | 141 | 81 | 4 | PF00595 | |
| Domain | RasGEFN | 3.36e-03 | 20 | 81 | 2 | SM00229 | |
| Domain | dsrm | 3.36e-03 | 20 | 81 | 2 | PF00035 | |
| Domain | RasGEF_N | 3.70e-03 | 21 | 81 | 2 | PF00618 | |
| Domain | PDZ | 3.93e-03 | 148 | 81 | 4 | SM00228 | |
| Domain | Ras-like_Gua-exchang_fac_N | 4.06e-03 | 22 | 81 | 2 | IPR000651 | |
| Domain | RASGEF_NTER | 4.06e-03 | 22 | 81 | 2 | PS50212 | |
| Domain | - | 4.12e-03 | 150 | 81 | 4 | 2.30.42.10 | |
| Domain | cEGF | 5.64e-03 | 26 | 81 | 2 | IPR026823 | |
| Domain | cEGF | 5.64e-03 | 26 | 81 | 2 | PF12662 | |
| Domain | AT_hook | 6.08e-03 | 27 | 81 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 6.08e-03 | 27 | 81 | 2 | IPR017956 | |
| Domain | dsRBD_dom | 6.53e-03 | 28 | 81 | 2 | IPR014720 | |
| Domain | FHA | 6.53e-03 | 28 | 81 | 2 | SM00240 | |
| Domain | RASGEF_CAT | 6.99e-03 | 29 | 81 | 2 | PS50009 | |
| Domain | RasGEF | 7.47e-03 | 30 | 81 | 2 | PF00617 | |
| Domain | - | 7.47e-03 | 30 | 81 | 2 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 7.47e-03 | 30 | 81 | 2 | IPR023578 | |
| Domain | RASGEF_cat_dom | 7.47e-03 | 30 | 81 | 2 | IPR001895 | |
| Domain | RasGEF | 7.47e-03 | 30 | 81 | 2 | SM00147 | |
| Domain | RA | 7.96e-03 | 31 | 81 | 2 | SM00314 | |
| Domain | HMGI/Y_DNA-bd_CS | 7.96e-03 | 31 | 81 | 2 | IPR000637 | |
| Domain | FHA_DOMAIN | 7.96e-03 | 31 | 81 | 2 | PS50006 | |
| Domain | FHA | 7.96e-03 | 31 | 81 | 2 | PF00498 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG MSH6 KRT8 DMXL2 SETX ZC3H13 DKC1 SREK1 LYAR EPB41L3 CWC22 MECP2 MED12 GTF3C3 AFF4 SACM1L NUP205 | 7.61e-10 | 1082 | 84 | 17 | 38697112 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SETX SLC4A1AP BAZ2B ZC3H13 MKI67 DKC1 GPATCH4 SREK1 LYAR EPB41L3 SSX2 MGA CWC22 MECP2 AFF4 | 8.53e-09 | 954 | 84 | 15 | 36373674 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MSH6 SETX SLC4A1AP EHMT2 BAZ2B MKI67 GPATCH4 LYAR MGA MECP2 GTF3C3 AFF4 | 2.63e-08 | 608 | 84 | 12 | 36089195 |
| Pubmed | MSH6 KRT8 SETX EHMT2 ZC3H13 WWP2 MKI67 DKC1 ZC3HC1 EPB41L3 USP47 | 3.73e-08 | 503 | 84 | 11 | 16964243 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MSH6 RAPGEF6 SLC4A1AP ZC3H13 MKI67 DKC1 AFF1 MECP2 REXO1 USP47 ANKS1A RAD50 | 3.54e-07 | 774 | 84 | 12 | 15302935 |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 6.17e-07 | 125 | 84 | 6 | 32891193 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 6.80e-07 | 410 | 84 | 9 | 26949251 | |
| Pubmed | 7.98e-07 | 418 | 84 | 9 | 34709266 | ||
| Pubmed | 1.17e-06 | 222 | 84 | 7 | 37071664 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 2.13e-06 | 349 | 84 | 8 | 25665578 | |
| Pubmed | MSH6 EHMT2 LRP1 GPATCH4 SREK1 CRYBG3 RAPGEF2 LYAR EPB41L3 MGA MECP2 AFF4 RAD50 | 2.70e-06 | 1116 | 84 | 13 | 31753913 | |
| Pubmed | SETX SLC30A5 EHMT2 MKI67 ZC3HC1 GPATCH4 RAPGEF2 EPB41L3 MGA SPTY2D1 GTF3C3 | 2.72e-06 | 777 | 84 | 11 | 35844135 | |
| Pubmed | 3.84e-06 | 378 | 84 | 8 | 34315543 | ||
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | 4.28e-06 | 270 | 84 | 7 | 24366813 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MSH6 SLC4A1AP MKI67 DKC1 SREK1 LYAR CWC22 SPTY2D1 GTF3C3 AFF4 NUP205 RAD50 | 4.51e-06 | 989 | 84 | 12 | 36424410 |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 37528066 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 34077112 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 18509036 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24843025 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24858808 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 31476380 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 28232158 | ||
| Pubmed | MeCP2 repression of G9a in regulation of pain and morphine reward. | 5.76e-06 | 2 | 84 | 2 | 24990928 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24126453 | ||
| Pubmed | Mice lacking GRIP1/2 show increased social interactions and enhanced phosphorylation at GluA2-S880. | 5.76e-06 | 2 | 84 | 2 | 28063882 | |
| Pubmed | NABP1, a novel RORgamma-regulated gene encoding a single-stranded nucleic-acid-binding protein. | 5.76e-06 | 2 | 84 | 2 | 16533169 | |
| Pubmed | Domain and functional analysis of a novel platelet-endothelial cell surface protein, SCUBE1. | 5.76e-06 | 2 | 84 | 2 | 18303018 | |
| Pubmed | Histone H3 lysine 9 methyltransferase G9a is a transcriptional coactivator for nuclear receptors. | 5.76e-06 | 2 | 84 | 2 | 16461774 | |
| Pubmed | GRIP1 and 2 regulate activity-dependent AMPA receptor recycling via exocyst complex interactions. | 5.76e-06 | 2 | 84 | 2 | 20956289 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 26007649 | ||
| Pubmed | Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse. | 5.76e-06 | 2 | 84 | 2 | 22357654 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 32600317 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | GRIP1 KRT8 NDC80 KATNB1 DKC1 LYAR MGA USP47 NUP205 ANKS1A RAD50 | 6.60e-06 | 853 | 84 | 11 | 28718761 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYH7 SETX LRP1 MGA MECP2 GTF3C3 ANKRD26P1 USP47 SACM1L NUP205 RAD50 | 6.90e-06 | 857 | 84 | 11 | 25609649 |
| Pubmed | MSH6 KRT8 ZC3H13 MKI67 DKC1 PIP5K1A GPATCH4 SREK1 LYAR GTF3C3 | 8.68e-06 | 713 | 84 | 10 | 29802200 | |
| Pubmed | 9.02e-06 | 17 | 84 | 3 | 23408915 | ||
| Pubmed | 1.24e-05 | 210 | 84 | 6 | 16565220 | ||
| Pubmed | 1.32e-05 | 591 | 84 | 9 | 15231748 | ||
| Pubmed | 1.49e-05 | 61 | 84 | 4 | 27166947 | ||
| Pubmed | 1.53e-05 | 128 | 84 | 5 | 23858473 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.59e-05 | 605 | 84 | 9 | 28977666 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 16732327 | ||
| Pubmed | GRIP1 is required for homeostatic regulation of AMPAR trafficking. | 1.73e-05 | 3 | 84 | 2 | 26216979 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 21383172 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 38123547 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 29747665 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 20101178 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 10588740 | ||
| Pubmed | Sox2 modulates the function of two distinct cell lineages in mouse skin. | 1.75e-05 | 21 | 84 | 3 | 23948231 | |
| Pubmed | 1.83e-05 | 469 | 84 | 8 | 27634302 | ||
| Pubmed | 2.62e-05 | 645 | 84 | 9 | 25281560 | ||
| Pubmed | 2.65e-05 | 24 | 84 | 3 | 34233187 | ||
| Pubmed | 2.65e-05 | 24 | 84 | 3 | 25348719 | ||
| Pubmed | Streamlined analysis schema for high-throughput identification of endogenous protein complexes. | 2.72e-05 | 71 | 84 | 4 | 20133760 | |
| Pubmed | DMXL2 RAPGEF6 SETX SLC30A5 GON4L PIP5K1A CRYBG3 CWC22 SACM1L | 2.79e-05 | 650 | 84 | 9 | 38777146 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 2.81e-05 | 498 | 84 | 8 | 36634849 | |
| Pubmed | 2.89e-05 | 653 | 84 | 9 | 22586326 | ||
| Pubmed | 3.17e-05 | 149 | 84 | 5 | 25184681 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 12458226 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 20223108 | ||
| Pubmed | A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency. | 3.45e-05 | 4 | 84 | 2 | 26830226 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 26366868 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 11641419 | ||
| Pubmed | Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4. | 3.45e-05 | 4 | 84 | 2 | 25282333 | |
| Pubmed | Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. | 3.45e-05 | 4 | 84 | 2 | 11923441 | |
| Pubmed | Mediation of Af4 protein function in the cerebellum by Siah proteins. | 3.45e-05 | 4 | 84 | 2 | 15459319 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MSH6 PCLO MKI67 DKC1 GPATCH4 SREK1 LYAR EPB41L3 CWC22 GTF3C3 SACM1L NUP205 RAD50 | 3.62e-05 | 1425 | 84 | 13 | 30948266 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GRIP1 KRT8 RAPGEF6 SETX WWP2 CRYBG3 RAPGEF2 EPB41L3 DENND2B ANKS1A | 4.34e-05 | 861 | 84 | 10 | 36931259 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 4.54e-05 | 533 | 84 | 8 | 30554943 | |
| Pubmed | Myomesin 3, a novel structural component of the M-band in striated muscle. | 5.74e-05 | 5 | 84 | 2 | 18177667 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 39164270 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 26725954 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 28270450 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 21227926 | ||
| Pubmed | PPARGC1A ZBTB6 RAPGEF6 SETX ZC3H13 POLG GRAMD2B AFF1 MGA SPTY2D1 AFF4 | 5.96e-05 | 1084 | 84 | 11 | 11544199 | |
| Pubmed | MSH6 SETX SLC4A1AP EHMT2 ASCC2 GON4L GPATCH4 SREK1 LYAR MECP2 SPTY2D1 MED12 AFF4 | 6.00e-05 | 1497 | 84 | 13 | 31527615 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SETX EHMT2 BAZ2B ZC3H13 MKI67 DKC1 GPATCH4 LYAR MGA MECP2 SPTY2D1 RAD50 | 6.37e-05 | 1294 | 84 | 12 | 30804502 |
| Pubmed | 6.61e-05 | 89 | 84 | 4 | 18950845 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 6.91e-05 | 90 | 84 | 4 | 35654790 | |
| Pubmed | 7.20e-05 | 177 | 84 | 5 | 26206133 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 7.25e-05 | 736 | 84 | 9 | 29676528 | |
| Pubmed | Single strand DNA binding proteins 1 and 2 protect newly replicated telomeres. | 8.59e-05 | 6 | 84 | 2 | 23459151 | |
| Pubmed | HSSB1 and hSSB2 form similar multiprotein complexes that participate in DNA damage response. | 8.59e-05 | 6 | 84 | 2 | 19605351 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 38961108 | ||
| Pubmed | Uterine glands impact embryo survival and stromal cell decidualization in mice. | 8.59e-05 | 6 | 84 | 2 | 34547143 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 33082503 | ||
| Pubmed | SSB1/SSB2 Proteins Safeguard B Cell Development by Protecting the Genomes of B Cell Precursors. | 8.59e-05 | 6 | 84 | 2 | 31085591 | |
| Pubmed | 8.72e-05 | 754 | 84 | 9 | 35906200 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 9.16e-05 | 759 | 84 | 9 | 35915203 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MSH6 SETX MKI67 DKC1 GPATCH4 LYAR EPB41L3 MGA MED12 GTF3C3 NUP205 RAD50 | 9.72e-05 | 1353 | 84 | 12 | 29467282 |
| Pubmed | 1.05e-04 | 601 | 84 | 8 | 33658012 | ||
| Pubmed | 1.08e-04 | 38 | 84 | 3 | 38196272 | ||
| Pubmed | SETX WWP2 MKI67 ASCC2 DKC1 GPATCH4 LYAR MECP2 SPTY2D1 GTF3C3 AFF4 NUP205 | 1.10e-04 | 1371 | 84 | 12 | 36244648 | |
| Pubmed | 1.17e-04 | 103 | 84 | 4 | 32744500 | ||
| Pubmed | Single-stranded DNA-binding protein hSSB1 is critical for genomic stability. | 1.20e-04 | 7 | 84 | 2 | 18449195 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 29451339 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 17704298 | ||
| Pubmed | Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation. | 1.20e-04 | 7 | 84 | 2 | 18691967 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 38788809 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 23886662 | ||
| Interaction | SNRNP40 interactions | SETX SLC4A1AP BAZ2B ZC3H13 MKI67 DKC1 GON4L GPATCH4 SREK1 MGA CWC22 MECP2 SPTY2D1 PRPF18 MED12 | 4.43e-08 | 637 | 83 | 15 | int:SNRNP40 |
| Interaction | HDAC1 interactions | GRIP1 MSH6 MYH7 RAPGEF6 EHMT2 WWP2 MKI67 ASCC2 GON4L AFF1 CRYBG3 EPB41L3 SSX2 MGA MECP2 MED12 USP47 RAD50 | 4.57e-07 | 1108 | 83 | 18 | int:HDAC1 |
| Interaction | NIFK interactions | EHMT2 WWP2 MKI67 DKC1 GPATCH4 SREK1 LYAR MECP2 SPTY2D1 AFF4 NUP205 | 1.53e-06 | 431 | 83 | 11 | int:NIFK |
| Interaction | NUP43 interactions | SETX BAZ2B ZC3H13 MKI67 DKC1 GON4L GPATCH4 SREK1 RAPGEF2 MGA CWC22 MECP2 MED12 | 1.56e-06 | 625 | 83 | 13 | int:NUP43 |
| Interaction | COIL interactions | MSH6 EHMT2 BAZ2B MKI67 DKC1 GPATCH4 MGA MECP2 SPTY2D1 GTF3C3 AFF4 NUP205 | 2.61e-06 | 552 | 83 | 12 | int:COIL |
| Interaction | SMC5 interactions | SETX SLC4A1AP BAZ2B ZC3H13 MKI67 DKC1 GPATCH4 SREK1 LYAR EPB41L3 SSX2 MGA CWC22 MECP2 AFF4 RAD50 | 2.70e-06 | 1000 | 83 | 16 | int:SMC5 |
| Interaction | MECP2 interactions | FLG MSH6 KRT8 DMXL2 SETX ZC3H13 MKI67 DKC1 SREK1 LYAR EPB41L3 CWC22 MECP2 MED12 GTF3C3 AFF4 SACM1L NUP205 | 3.89e-06 | 1287 | 83 | 18 | int:MECP2 |
| Interaction | NLE1 interactions | 4.52e-06 | 228 | 83 | 8 | int:NLE1 | |
| Interaction | POLR1G interactions | SLC4A1AP BAZ2B DKC1 GPATCH4 LYAR MGA MECP2 GTF3C3 AFF4 NUP205 RAD50 | 5.13e-06 | 489 | 83 | 11 | int:POLR1G |
| Interaction | H3C3 interactions | MSH6 SETX EHMT2 BAZ2B MKI67 GPATCH4 LYAR MGA MECP2 GTF3C3 AFF4 | 5.76e-06 | 495 | 83 | 11 | int:H3C3 |
| Interaction | ZNF330 interactions | MSH6 SLC4A1AP DKC1 GPATCH4 LYAR MECP2 SPTY2D1 GTF3C3 AFF4 NUP205 | 1.46e-05 | 446 | 83 | 10 | int:ZNF330 |
| Interaction | H2BC8 interactions | MSH6 SLC4A1AP EHMT2 POLG MKI67 GON4L ZC3HC1 GPATCH4 LYAR MGA MECP2 | 2.37e-05 | 576 | 83 | 11 | int:H2BC8 |
| Interaction | PIP4K2A interactions | 3.07e-05 | 216 | 83 | 7 | int:PIP4K2A | |
| Interaction | SNRNP70 interactions | MSH6 KRT8 ZC3H13 WWP2 MKI67 LRP1 DKC1 PIP5K1A GPATCH4 SREK1 LYAR CWC22 MECP2 GTF3C3 | 4.53e-05 | 984 | 83 | 14 | int:SNRNP70 |
| Interaction | GPATCH4 interactions | 4.83e-05 | 232 | 83 | 7 | int:GPATCH4 | |
| Interaction | H2AC17 interactions | 4.83e-05 | 232 | 83 | 7 | int:H2AC17 | |
| Interaction | SIRT6 interactions | MSH6 MYH7 EHMT2 MKI67 ASCC2 DKC1 MED12 GTF3C3 NUP205 ANKS1A RAD50 | 5.20e-05 | 628 | 83 | 11 | int:SIRT6 |
| Interaction | SMC1A interactions | 5.52e-05 | 418 | 83 | 9 | int:SMC1A | |
| Interaction | DGCR8 interactions | 6.31e-05 | 242 | 83 | 7 | int:DGCR8 | |
| Interaction | MED12 interactions | 8.81e-05 | 176 | 83 | 6 | int:MED12 | |
| Interaction | FGFBP1 interactions | 9.20e-05 | 257 | 83 | 7 | int:FGFBP1 | |
| Interaction | POLR1E interactions | 9.71e-05 | 350 | 83 | 8 | int:POLR1E | |
| Interaction | SSRP1 interactions | MSH6 SETX ZC3H13 WWP2 NABP2 DKC1 SREK1 LYAR MECP2 SPTY2D1 REXO1 | 1.13e-04 | 685 | 83 | 11 | int:SSRP1 |
| Interaction | AFF4 interactions | 1.13e-04 | 115 | 83 | 5 | int:AFF4 | |
| Interaction | SLX4 interactions | MSH6 BAZ2B MKI67 GPATCH4 MGA SPTY2D1 REXO1 GTF3C3 AFF4 RAD50 | 1.19e-04 | 572 | 83 | 10 | int:SLX4 |
| Interaction | EPB41L3 interactions | 1.31e-04 | 272 | 83 | 7 | int:EPB41L3 | |
| Interaction | LYAR interactions | 1.50e-04 | 373 | 83 | 8 | int:LYAR | |
| Interaction | DDX23 interactions | 1.58e-04 | 480 | 83 | 9 | int:DDX23 | |
| Interaction | AFF1 interactions | 1.59e-04 | 66 | 83 | 4 | int:AFF1 | |
| Interaction | ADARB1 interactions | 1.81e-04 | 489 | 83 | 9 | int:ADARB1 | |
| Interaction | RBBP5 interactions | 1.82e-04 | 287 | 83 | 7 | int:RBBP5 | |
| Interaction | RCOR1 interactions | 1.96e-04 | 494 | 83 | 9 | int:RCOR1 | |
| Interaction | RNF2 interactions | PPARGC1A EHMT2 WWP2 PCLO MKI67 DKC1 GPATCH4 LYAR SSX2 MGA NUP205 RAD50 | 2.14e-04 | 866 | 83 | 12 | int:RNF2 |
| Interaction | SRSF6 interactions | 2.24e-04 | 503 | 83 | 9 | int:SRSF6 | |
| Interaction | RPS6 interactions | WWP2 PCLO MKI67 ASCC2 DKC1 GPATCH4 SREK1 LYAR MECP2 SPTY2D1 GTF3C3 NUP205 | 2.33e-04 | 874 | 83 | 12 | int:RPS6 |
| Interaction | SRSF4 interactions | 2.39e-04 | 300 | 83 | 7 | int:SRSF4 | |
| Interaction | USP53 interactions | 2.65e-04 | 138 | 83 | 5 | int:USP53 | |
| Interaction | AURKB interactions | MSH6 ADRA1D SETX NDC80 MKI67 HEATR5A CRYBG3 LYAR GTF3C3 NUP205 RAD50 | 2.81e-04 | 761 | 83 | 11 | int:AURKB |
| Interaction | MEN1 interactions | EHMT2 ZC3H13 SETBP1 MKI67 DKC1 ZC3HC1 GPATCH4 SREK1 LYAR MED12 GTF3C3 AFF4 NUP205 | 2.83e-04 | 1029 | 83 | 13 | int:MEN1 |
| Interaction | CWC22 interactions | 2.93e-04 | 141 | 83 | 5 | int:CWC22 | |
| Interaction | CDK8 interactions | 3.11e-04 | 222 | 83 | 6 | int:CDK8 | |
| Interaction | ZBTB38 interactions | 3.33e-04 | 145 | 83 | 5 | int:ZBTB38 | |
| Interaction | CCNT1 interactions | 3.34e-04 | 225 | 83 | 6 | int:CCNT1 | |
| Interaction | ROGDI interactions | 3.36e-04 | 33 | 83 | 3 | int:ROGDI | |
| Interaction | ARL4D interactions | 3.44e-04 | 146 | 83 | 5 | int:ARL4D | |
| Interaction | FMR1 interactions | 3.57e-04 | 536 | 83 | 9 | int:FMR1 | |
| Interaction | CHAMP1 interactions | 3.66e-04 | 148 | 83 | 5 | int:CHAMP1 | |
| Interaction | ARL16 interactions | 3.84e-04 | 83 | 83 | 4 | int:ARL16 | |
| Interaction | ASB3 interactions | 4.02e-04 | 84 | 83 | 4 | int:ASB3 | |
| Interaction | RPF2 interactions | 4.31e-04 | 236 | 83 | 6 | int:RPF2 | |
| Interaction | TERF2IP interactions | 4.42e-04 | 552 | 83 | 9 | int:TERF2IP | |
| Interaction | KDM1A interactions | MSH6 RAPGEF6 SLC4A1AP EHMT2 LRP1 ASCC2 CRYBG3 EPB41L3 MGA MED12 GTF3C3 RAD50 | 4.56e-04 | 941 | 83 | 12 | int:KDM1A |
| Interaction | FGF12 interactions | 4.59e-04 | 87 | 83 | 4 | int:FGF12 | |
| Interaction | SSX6P interactions | 4.62e-04 | 8 | 83 | 2 | int:SSX6P | |
| Interaction | NHLH1 interactions | 4.79e-04 | 88 | 83 | 4 | int:NHLH1 | |
| Interaction | INTS5 interactions | 4.93e-04 | 158 | 83 | 5 | int:INTS5 | |
| Interaction | CSNK2A1 interactions | FLG MSH6 SLC4A1AP EHMT2 ZC3H13 WWP2 DKC1 SREK1 EPB41L3 MGA MECP2 GTF3C3 | 5.25e-04 | 956 | 83 | 12 | int:CSNK2A1 |
| Interaction | MDK interactions | 5.44e-04 | 91 | 83 | 4 | int:MDK | |
| Interaction | YY1 interactions | 5.62e-04 | 454 | 83 | 8 | int:YY1 | |
| Interaction | H2BC21 interactions | PPARGC1A MSH6 EHMT2 WWP2 PCLO NABP2 MKI67 EPB41L3 MECP2 RAD50 | 5.67e-04 | 696 | 83 | 10 | int:H2BC21 |
| Interaction | KLF9 interactions | 5.91e-04 | 93 | 83 | 4 | int:KLF9 | |
| Interaction | MAGEB2 interactions | 5.91e-04 | 349 | 83 | 7 | int:MAGEB2 | |
| Interaction | TATDN3 interactions | 5.92e-04 | 9 | 83 | 2 | int:TATDN3 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.54e-05 | 15 | 60 | 3 | 26 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 6.47e-05 | 4 | 60 | 2 | 1145 | |
| GeneFamily | PDZ domain containing | 1.48e-04 | 152 | 60 | 5 | 1220 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 3.84e-04 | 9 | 60 | 2 | 1280 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 5.84e-04 | 11 | 60 | 2 | 1025 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | PPARGC1A RAPGEF6 SETX SLC30A5 NDC80 SLC4A1AP BAZ2B PLXNC1 MKI67 SREK1 EPB41L3 USP47 SACM1L RAD50 | 1.51e-08 | 656 | 82 | 14 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MSH6 DMXL2 SETX NDC80 BAZ2B PIP5K1A AFF1 CRYBG3 RAPGEF2 MECP2 DENND2B ANKS1A | 1.38e-05 | 856 | 82 | 12 | M4500 |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 1.64e-05 | 171 | 82 | 6 | M2947 | |
| Coexpression | WANG_LMO4_TARGETS_DN | 1.76e-05 | 361 | 82 | 8 | M12674 | |
| Coexpression | HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2 | 1.94e-05 | 17 | 82 | 3 | M9940 | |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP | 3.85e-05 | 199 | 82 | 6 | M9491 | |
| Coexpression | GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN | 3.85e-05 | 199 | 82 | 6 | M6030 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN | 3.96e-05 | 200 | 82 | 6 | M8648 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | GRIP1 PPARGC1A DMXL2 SLC4A1AP PLXNC1 PCLO SETBP1 MKI67 GON4L LYAR MECP2 AFF4 RAD50 | 9.64e-06 | 831 | 78 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 2.90e-05 | 48 | 78 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | MSH6 DMXL2 SETX DKC1 HEATR5A NABP1 LYAR ZW10 CWC22 GTF3C3 NUP205 RAD50 | 3.13e-05 | 795 | 78 | 12 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 8.03e-05 | 493 | 78 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.43e-04 | 532 | 78 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.63e-04 | 221 | 78 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K5 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.77e-06 | 193 | 84 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-05 | 157 | 84 | 5 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-05 | 157 | 84 | 5 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 173 | 84 | 5 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 173 | 84 | 5 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.57e-05 | 184 | 84 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.85e-05 | 188 | 84 | 5 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-05 | 188 | 84 | 5 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.93e-05 | 189 | 84 | 5 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.00e-05 | 190 | 84 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.08e-05 | 191 | 84 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-05 | 192 | 84 | 5 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | HSPCs-Ery_prog.|World / Lineage and Cell class | 3.23e-05 | 193 | 84 | 5 | 484c2e0daedc6cb0d50d164add8c1658123a60f9 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-05 | 194 | 84 | 5 | de9c7c602d886d0cd8bbd1d7e7744f84df951238 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-05 | 194 | 84 | 5 | 49441ca0a8fa34cb847fecbb4b809dd01d879ebb | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 3.48e-05 | 196 | 84 | 5 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.48e-05 | 196 | 84 | 5 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-05 | 197 | 84 | 5 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.57e-05 | 197 | 84 | 5 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 3.57e-05 | 197 | 84 | 5 | 98d4107e457e7399a84439acd73bf8f59598971b | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.57e-05 | 197 | 84 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.65e-05 | 198 | 84 | 5 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-05 | 198 | 84 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-05 | 198 | 84 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-05 | 198 | 84 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.74e-05 | 199 | 84 | 5 | 5b6feacb0ca92c3fc6b327be978320426dcf6f68 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 4e0b73d88b1345ec63a9e5629762341e75beb47f | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.74e-05 | 199 | 84 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.74e-05 | 199 | 84 | 5 | 372fb9eb90022dc4ac770a75b4e207c33d1d0c43 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-05 | 199 | 84 | 5 | 26bb93347e6722abd174dfa62cab692ce2b7eb23 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.74e-05 | 199 | 84 | 5 | dd3bf59cdc18091889cbf6c43f37100ba537843d | |
| ToppCell | cellseq2-Immune-Immune_Myeloid|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.74e-05 | 199 | 84 | 5 | 6c3c9eceea20121ae17ae2462134aa0437f591b3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.83e-05 | 200 | 84 | 5 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | 5432bdf495431cd26f6e4cd585100f3652588913 | |
| ToppCell | Sigmoid-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 3.83e-05 | 200 | 84 | 5 | 372fe9018481a4e9ac6ab3af43705a48238c4376 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | 8872d5fa101d413fb43b4231d476878678543035 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-04 | 160 | 84 | 4 | 731def6d82814ebac1a400bc7aea5f6da43ec960 | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 2.38e-04 | 160 | 84 | 4 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-04 | 160 | 84 | 4 | cf27b4ac4d0caa6f9b068dc8ea93472470a01a4d | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 2.44e-04 | 161 | 84 | 4 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-04 | 163 | 84 | 4 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-04 | 163 | 84 | 4 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 164 | 84 | 4 | 4307b002fb41ddfc7ab8a6bca66a60942c250052 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 164 | 84 | 4 | 1d84aa5b925f502ee9c5fa39714490f613a58028 | |
| ToppCell | 343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-04 | 166 | 84 | 4 | a54377c703efff42d2cc1a8fdb610facc58053dd | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.93e-04 | 169 | 84 | 4 | 2098f15a388d019ed7f1d4c209affd5ca2886dcc | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-04 | 170 | 84 | 4 | fed8e982d2ce234c59d4016432ed8941df36df27 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-04 | 170 | 84 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.07e-04 | 171 | 84 | 4 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.14e-04 | 172 | 84 | 4 | 35e961c88bfe79046533396912cedf00ca81db7b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 175 | 84 | 4 | e991ffa4d1d278a011592b9915cd35fe76db20cc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_GRIP2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.35e-04 | 175 | 84 | 4 | 0c648e7f67ffbe3b476a2ca77d246554f8cd1882 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.42e-04 | 176 | 84 | 4 | 270d7908dbd84028958d257f94941dc685e20255 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-04 | 177 | 84 | 4 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 178 | 84 | 4 | a9a8567d8fdc0fffd612fee16b5b29ef7b1c9307 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 178 | 84 | 4 | 5ecbea15efd304057aef826ec2f385997bfaf0c9 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-04 | 179 | 84 | 4 | 8bf04a7ad1b0be6722ebfdceba3f083f07bf96c5 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 3.72e-04 | 180 | 84 | 4 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.72e-04 | 180 | 84 | 4 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.80e-04 | 181 | 84 | 4 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.80e-04 | 181 | 84 | 4 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-04 | 182 | 84 | 4 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.88e-04 | 182 | 84 | 4 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-04 | 182 | 84 | 4 | 57f8b8d7b132f3ad6f2b1e79c3812fe938657d2c | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 3.96e-04 | 183 | 84 | 4 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 3.96e-04 | 183 | 84 | 4 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-04 | 184 | 84 | 4 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.13e-04 | 185 | 84 | 4 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-04 | 185 | 84 | 4 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.13e-04 | 185 | 84 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 185 | 84 | 4 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.22e-04 | 186 | 84 | 4 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.22e-04 | 186 | 84 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.22e-04 | 186 | 84 | 4 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.22e-04 | 186 | 84 | 4 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.22e-04 | 186 | 84 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 4.30e-04 | 187 | 84 | 4 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.39e-04 | 188 | 84 | 4 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 188 | 84 | 4 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 188 | 84 | 4 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 4.39e-04 | 188 | 84 | 4 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-04 | 188 | 84 | 4 | d534ed9870405a3c1075962308f72b460aed17bf | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 189 | 84 | 4 | b81540e097e95158851e07bfd78640ed6e64c2cf | |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | 4.48e-04 | 189 | 84 | 4 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 4.48e-04 | 189 | 84 | 4 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 189 | 84 | 4 | 0fda1a3f1e87fadf5309c8267beaa4501983b1dd | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.48e-04 | 189 | 84 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.48e-04 | 189 | 84 | 4 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.48e-04 | 189 | 84 | 4 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 4.48e-04 | 189 | 84 | 4 | 74a5e61cd820f2495dde40e766c771a31d8c4e7d | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.57e-04 | 190 | 84 | 4 | 47513757e0059e8370e49672a577f25ca842e98c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.57e-04 | 190 | 84 | 4 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.57e-04 | 190 | 84 | 4 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-04 | 190 | 84 | 4 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.57e-04 | 190 | 84 | 4 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.57e-04 | 190 | 84 | 4 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.57e-04 | 190 | 84 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.66e-04 | 191 | 84 | 4 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 4.66e-04 | 191 | 84 | 4 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| Disease | white matter hyperintensity measurement | 1.84e-05 | 302 | 80 | 7 | EFO_0005665 | |
| Disease | Mental Retardation, Psychosocial | 3.91e-05 | 139 | 80 | 5 | C0025363 | |
| Disease | Profound Mental Retardation | 3.91e-05 | 139 | 80 | 5 | C0020796 | |
| Disease | Mental deficiency | 3.91e-05 | 139 | 80 | 5 | C0917816 | |
| Disease | diastolic blood pressure, systolic blood pressure | 8.39e-05 | 670 | 80 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | asthma | 1.98e-04 | 751 | 80 | 9 | MONDO_0004979 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.14e-04 | 447 | 80 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | parental longevity | 3.91e-04 | 494 | 80 | 7 | EFO_0007796 | |
| Disease | executive function measurement | 5.59e-04 | 376 | 80 | 6 | EFO_0009332 | |
| Disease | Pontoneocerebellar hypoplasia | 8.50e-04 | 16 | 80 | 2 | cv:C1261175 | |
| Disease | Multiple congenital anomalies | 9.61e-04 | 17 | 80 | 2 | C0000772 | |
| Disease | cardiomyopathy (is_implicated_in) | 1.20e-03 | 19 | 80 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | Intellectual Disability | 1.37e-03 | 447 | 80 | 6 | C3714756 | |
| Disease | age at menopause | 1.40e-03 | 302 | 80 | 5 | EFO_0004704 | |
| Disease | Epilepsy, Cryptogenic | 1.46e-03 | 82 | 80 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.46e-03 | 82 | 80 | 3 | C0751111 | |
| Disease | Aura | 1.46e-03 | 82 | 80 | 3 | C0236018 | |
| Disease | complement factor D measurement | 2.09e-03 | 93 | 80 | 3 | EFO_0020283 | |
| Disease | breast cancer (implicated_via_orthology) | 2.09e-03 | 25 | 80 | 2 | DOID:1612 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKRDSLGTAGSAHLI | 21 | Q8TDH9 | |
| VESHSGRGKTISLSK | 826 | Q68DQ2 | |
| RIIHAKKTGKRDTSG | 1256 | Q9UIF8 | |
| DSVDLSRVHKGKSTR | 551 | Q9H1I8 | |
| GKLHRAASRGEVSKV | 51 | Q6NSI1 | |
| LEKETRGATERVHGS | 26 | Q96KQ7 | |
| VVLVDGKTKDHRRSS | 466 | Q92625 | |
| DAGEGTKRHLSRTIS | 1386 | Q8TDJ6 | |
| SKSPRETGGKRHESS | 141 | P20930 | |
| GHGSRKESSAVLSRI | 271 | P78524 | |
| SKDPKTEHGSRKRTI | 821 | Q9UHB7 | |
| GSLGHKTASASKRVL | 41 | Q8NFF2 | |
| GVITRTKHGEKVSLS | 116 | Q92878 | |
| RGHLRTKIESGEGTV | 516 | Q9NS39 | |
| LGSSGKTIHELEKVR | 1516 | P12883 | |
| RGLGSEKHRKEVSDL | 206 | Q92621 | |
| SLAGKHGDDLRRTKT | 291 | P05787 | |
| SRGHETSGKGLEKTS | 311 | Q8IWI9 | |
| RTGESRHKTRGDKIA | 441 | Q8IYT1 | |
| SDRTHANGSIKRGSK | 2111 | Q07954 | |
| ISGLVKSKSGLSGRH | 626 | Q9BVA0 | |
| GHGKTRSKEVDKLIR | 721 | Q9HCG8 | |
| ESRAHTGSSSRGKRK | 406 | Q5T3I0 | |
| GKHRRLTRKSSTSID | 1606 | Q9Y6V0 | |
| RIKITRDSKDHTVSG | 4496 | Q9Y6V0 | |
| AAVGVTRHKSKELSR | 961 | O60486 | |
| HRSGASRRLEKKTVT | 136 | Q8NDH3 | |
| LQGRKSRGTDLHSKT | 921 | P54098 | |
| LEKGQHLGSSSRKER | 1451 | Q93074 | |
| TQTHRETAGDGKSIK | 2026 | P46013 | |
| DGTFIREKGKSVRVH | 116 | P52701 | |
| IKKIGHRSVDSSGET | 61 | Q99755 | |
| SSVLTGGHEERKTKR | 361 | Q9UBK2 | |
| DKLKSARDVVTRTGH | 896 | Q86XA9 | |
| SSKTRDAGRRHVSGK | 2056 | Q3T8J9 | |
| VGAGKRKRRHSEVET | 266 | Q9NX58 | |
| VISDIKKGSVAHRTG | 601 | Q9Y3R0 | |
| SDIKKGSVAHRTGTL | 586 | Q9C0E4 | |
| VLGKRESKLGSAHSE | 16 | Q96HH9 | |
| RILRVEKTGHSGTLD | 111 | O60832 | |
| RGRKSPSKEVSHITA | 536 | Q8IWY4 | |
| KTDFTRTGKRTHLGL | 456 | Q9NTJ5 | |
| RLGSSTDKKDSGRLH | 201 | Q8TC92 | |
| HITKTVKGGISETRI | 1021 | Q9Y2J2 | |
| ITKGKLHGSIDVRLS | 86 | Q9BZF2 | |
| TLHIVKRGDGTRGET | 121 | Q16557 | |
| KHRGEGERKDIVSSS | 451 | P51608 | |
| VKISGDASTKAHRGV | 216 | Q9NYV8 | |
| GLSKTSGRRVVSHEV | 881 | Q8N1G1 | |
| KHRDEGRKTGSQRSS | 281 | A6NNA2 | |
| DRSGTRKGHIVIKAT | 406 | Q8TEU7 | |
| GRVTKTKDGHEVRSC | 31 | Q96AH0 | |
| QHLEDGDGKRKRSSS | 191 | Q7Z6J9 | |
| RDHGKTVGVVDTRKK | 1311 | Q7Z333 | |
| ERKGGRSRSHTRSKS | 186 | Q8WXA9 | |
| ESVGTKLSKGSGDRH | 236 | Q68D10 | |
| EGETSDGVRKSVHKV | 71 | Q9Y5Q9 | |
| RRVEGKGSRSSSEHK | 916 | P51825 | |
| RAKVSSLSHKIRAGG | 511 | P25100 | |
| RDVIAGRGIHSKVKS | 6 | Q6P3X8 | |
| DHRTDERKTTIKLGS | 226 | Q86WB0 | |
| DRTGTRKGHIVIKGT | 261 | Q9Y4G8 | |
| RKGHIVIKGTSERLT | 266 | Q9Y4G8 | |
| KVTTHELKEGGESIR | 681 | O00308 | |
| RADSHKGTSKRLQGS | 276 | O14709 | |
| SSGTTHKRILTGEKP | 226 | P0CB33 | |
| REATKKSRHGLDSIT | 151 | Q5T0L3 | |
| TTSEKIHERSGPKRG | 146 | Q16385 | |
| AAEVTRKSHRGLGES | 261 | Q6ZVD7 | |
| SSSEKIHERSGPKRG | 146 | Q7RTT6 | |
| HLEGRTGTAEKKLAS | 66 | Q8TD17 | |
| SKQRRHSSEGGVKSS | 561 | Q5TEJ8 | |
| RGGTRSILKTHFEKE | 26 | Q6U841 | |
| TGRVTKTKDGHEVRT | 26 | Q9BQ15 | |
| RITQEDIKKTHGGSS | 526 | Q96K76 | |
| RKSKRRSGEGSHLTT | 216 | P0DPA3 | |
| HTASRKLSVDVGGAK | 221 | Q8TAD4 | |
| KVGSASLSSGRLHKR | 1136 | Q9Y6X0 | |
| VGIHARTGREKIFSK | 286 | Q99633 | |
| SSRGRHREKEDIKIT | 116 | Q5T200 | |
| RVLHSGSRDREKTKS | 1226 | Q5T200 | |
| HSGRLEKEDLGTRIS | 11 | O43264 | |
| LTSVHGRSSGEKLSR | 401 | Q15916 | |
| GSTLDGVSRKKLHLR | 546 | Q9BWU0 | |
| HKDKRLESGDRIRTG | 1256 | Q5VTT5 | |
| KAETKLHTSNSGGRR | 66 | Q8WU39 | |
| ERKVSLFGKRTSGHG | 51 | O14777 |